Of the 11 species and 12 serogroups of Legionella described, only Legionella oakridgensis and L. sainthelensi have not yet been associated with human infections (1, 6) . We describe a case in which L. oakridgensis has been implicated as the cause of a human infection.
A 38-year-old woman was admitted in April 1984 to a local hospital for progressive systemic sclerosis (diagnosed in January 1984), renal failure, and cardiomyopathy.
The patient was on prednisone (40 mg daily) from March 1984 on in an attempt to control her progressive renal insufficiency and myopathy. After 4 weeks in the hospital, a dry cough, tachypnea, and hypoxemia without fever developed. Chest films showed consolidation of the anterior segment of the right upper lobe and of the superior segment of the right lower lobe, along with bilateral pleural effusions. Aspiration pneumonia was considered in the differential diagnosis, and treatment was begun with clindamycin (600 mg every 6 h intravenously [i.v.]), erythromycin (250 mg every 6 h i.v.), and tobramycin (80 mg once i.v. and subsequently in dialysis fluids).
A right lung biopsy was performed. Routine bacteriological examination of the biopsy specimen yielded a scant growth (a few colonies each) of Streptococcus faecalis, Serratia marcescens, and Morganella morganii.
Direct fluoresent-antibody testing (2) for Legionella spp.
was performed with the following 19 conjugates prepared in our laboratory as described previously (2): L. pneumophila serogroups 1 through 8, L. bozemanii serogroups 1 and 2, L. After the diagnosis of legionelosis was made, erythromycin (500 mg every 6 h i.v.) and cefotaxime (500 mg every 6 h i.v.) were administered, the other antimicrobial agents were discontinued, and prednisone was tapered gradually to 25 mg daily. Over the next month there was a slow, but steady, clinical and radiological improvement, although the patient remained seriously ill from her underlying disease.
Five days after the 4-week course of erythromycin (1 week i.v. and 3 weeks orally) was finished, fever, shock, and respiratory failure developed abruptly, along with a new right-lung infiltrate. S. marcescens was cultured from blood and sputum, and the patient died 3 days later of adult respiratory distress syndrome. Permission for autopsy was denied.
The direct fluorescent-antibody test results showed brightly fluorescent (4+), morphologically typical organisms against conjugates of L. oakridgensis and L. pneumophila serogroup 6 at >50 and 25 to 30 cells per smear, respectively. No fluorescence was observed either with the other 17 Legionella conjugates used or with the 3 bacterial species isolated from the lung biopsy specimen as a scant growth. Serum samples collected 5 days apart demonstrated at least a fourfold seroconversion in the indirect fluorescent-antibody test (from <1:32 for the first serum sample to 1:128 for the second) against L. oakridgensis only; the reaction for all other 18 antigens used, including L. pneumophila serogroup 6, was negative at a screening dilution of 1:32. The tube agglutination technique (4), which in our laboratory has always proven to be very specific, yielded negative results (<1:8) for the first serum sample and at least a fourfold rise to 1:32 for the second with L. oakridgensis antigen only. No growth of Legionella spp. was observed on any of the culture media. This may be the result of antibiotic treatment a few days before the biopsy was performed.
L. oakridgensis was originally isolated from industrial cooling towers and has not yet been incriminated in human infections, although its pathogenicity for guinea pigs suggests that it may be an unrecognized human pathogen (6 
